The True Liquid Biopsy
January 31, 2019
ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection
June 26, 2018
Bio-Techne To Acquire Exosome Diagnostics, Inc.
June 13, 2018
Exosome Diagnostics Achieves ISO 13485:2016 Certification
View all press releases
March 22, 2018
“Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor,” GenomeWeb
December 18, 2017
“Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test,” GenomeWeb
August 28, 2017
“Private Payor, ExoDx band together for studies on diagnostic tests,” MedCity News
View all news
Sign up to receive news and announcements
For media inquiries and general information
Download our company overview brochure to learn more.
Read about the 3 types of liquid biopsies in this Translational Cancer Research article.
© Exosome Diagnostics 2019